ABOUT US

ZHONGCHAO INC. (NasdaqCM: ZCMD)

Zhongchao Inc. a holding company incorporated under the laws of the Cayman Islands, through its variable interest entity and subsidiaries, provides healthcare information, education, and training services to healthcare professionals and the public in China. The Company commenced its operation, through Zhongchao Shanghai, in August 2012 with a vision to offer a wide range of accessible and immediate healthcare information and continuous learning and training opportunities for Chinese healthcare professionals.

More

Stock Chart
News
  • 01 2023 New Years Greetings

    Dear all: Happy New Year! The tiger year is revitalized, the rabbit year welcomes the prosperous world and starts a new journey! Its time to welcome the new year again, on behalf of all the staff of our company, I would like to wish you a happy New Year! I wish you family reunion, happiness and health, and all the best!

  • 02 Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment

    Shanghai, China, January 19, 2023 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), one of the China operating entities of which the Company consolidates the financial results with through certain contractual arrangements, launched the Medication Management Assistance Mini Program on WeChat (the “Program”) to assist cancer patients in managing multiple issues during the medication and facilitate whole treatment process.

  • 03 Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited

    Shanghai, China, January 4, 2023 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that Chongqing Xinjiang Pharmaceutical Co., Ltd. ("Xinjiang Pharmaceutical"), one of the Chinese operating entities of which the Company consolidates the financial results with through certain contractual arrangements, will act as the drug distribution agent of certain drugs produced by Natco Pharma Limited (“Natco”) within Mainland China pursuant to certain agreements. Natco is a vertically integrated and R&D focused pharmaceutical company in India.

  • 04 Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform

    Shanghai, China, December 5, 2022 /PRNewswire/-- Zhongchao Inc. (NASDAQ: ZCMD) (“Zhongchao” or the “Company”), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced that after three years of preparation, the Company’s MDMOOC platform has established a “Surgical-Interventional-Drug” (“SID”) platform for liver cancer comprehensive-disciplinary physician education (“SID Platform”), providing physicians with knowledge and techniques in comprehensive-disciplinary comprehensive management of patients with liver cancer.